A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiency.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Thrombosis Research

• Publication date

  2000-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0049-3848(00)00291-7PMID 11053623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Naturally occurring Arg(-1) to His mutation in human protein C leads to aberrant propeptide processing and secretion of dysfunctional protein C.

  1997cited by this paper
• Protein C Osaka 10 with Aberrant Propeptide Processing: Loss of Anticoagulant Activity Due to an Amino Acid Substitution in the Protein C Precursor

  1995cited by this paper
• Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX.

  1995cited by this paper
• Protein C Deficiency: A Database of Mutations, 1995 Update

  1995cited by this paper
• The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1.

  1994cited by this paper
• A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg‐1 results in a strongly reduced affinity for binding of Ca++

  1993cited by this paper
• Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activity.

  1993cited by this paper
• A microsomal endopeptidase from liver with substrate specificity for processing proproteins such as the vitamin K-dependent proteins of plasma.

  1992cited by this paper
• Molecular basis of vitamin K-dependent gamma-carboxylation.

  1990cited by this paper
• Molecular Forms of Human Protein C: Comparison and Distribution in Human Adult Plasma

  1989cited by this paper
• Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior.

  1989cited by this paper
• Amino-terminal alanine functions in a calcium-specific process essential for membrane binding by prothrombin fragment 1.

  1988cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• The regulation of natural anticoagulant pathways

  1987cited by this paper
• Analytical and clinical evaluation of commercial protein C assays.

  1987cited by this paper
• Propeptide of human protein C is necessary for gamma-carboxylation.

  1987cited by this paper
• Evolution and organization of the human protein C gene.

  1986cited by this paper
• The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs.

  1985cited by this paper
• The nucleotide sequence of the gene for human protein C.

  1985cited by this paper
• Protein-C: biochemistry, physiology, and clinical implications.

  1983cited by this paper
• Deficiency of protein C in congenital thrombotic disease.

  1981cited by this paper
• Anticoagulant properties of bovine plasma protein C following activation by thrombin.

  1977cited by this paper

• Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening.

  2024cites this paper
• Laboratory Limitations of Excluding Hereditary Protein C Deficiency by Chromogenic Assay: Discrepancies of Phenotype and Genotype

  2020cites this paper
• Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

  2019cites this paper
• Diagnostic Exome Sequencing Identifies a Novel Gene, EMILIN1, Associated with Autosomal‐Dominant Hereditary Connective Tissue Disease

  2015cites this paper